Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Ailani

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Dental Clinics of North America|March 25, 2023
Temporomandibular Joint Disorder ComorbiditiesDavis C Thomas, Junad Khan, Daniele Manfredini, et al.
Cephalalgia : an International Journal of Headache|July 9, 2025
Rimegepant safety and patient-reported outcomes among triptan-naïve, triptan-using, and triptan-failure participants: Subgroup analysis of an open-label, multicenter studyJessica Ailani, Jelena Pavlovic, Glenn C Pixton, et al.
Headache|July 11, 2019
Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster HeadacheRashmi B Halker Singh, Jessica Ailani, Matthew S Robbins
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of MigraineJessica Ailani, Liron Rabany, Shira Tamir, et al.
Headache|November 4, 2025
Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine studyJessica Ailani, Larry Charleston, Shannon Strom, et al.
The Journal of Headache and Pain|October 18, 2020
Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)Jessica Ailani, J Scott Andrews, Mallikarjuna Rettiganti, et al.
Pain and Therapy|April 24, 2023
The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative ReviewJessica Ailani, Stephanie J Nahas, Deborah I Friedman, et al.
Clinical Neurology and Neurosurgery|March 14, 2022
A retrospective evaluation of the combination of erenumab and onabotulinum toxin A for the prevention of chronic migraineArathi S Nandyala, Himanshu Suri, Carrie O Dougherty, et al.
Brain Sciences|December 31, 2016
An Unusual Case of Post-Traumatic Headache Complicated by Intracranial HypotensionSara Siavoshi, Carrie Dougherty, Jessica Ailani, et al.
Cephalalgia : an International Journal of Headache|January 31, 2023
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative reviewBianca Raffaelli, Roberto De Icco, Michele Corrado, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Dental Clinics of North America|March 25, 2023
Temporomandibular Joint Disorder ComorbiditiesDavis C Thomas, Junad Khan, Daniele Manfredini, et al.
Cephalalgia : an International Journal of Headache|July 9, 2025
Rimegepant safety and patient-reported outcomes among triptan-naïve, triptan-using, and triptan-failure participants: Subgroup analysis of an open-label, multicenter studyJessica Ailani, Jelena Pavlovic, Glenn C Pixton, et al.
Headache|July 11, 2019
Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster HeadacheRashmi B Halker Singh, Jessica Ailani, Matthew S Robbins
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of MigraineJessica Ailani, Liron Rabany, Shira Tamir, et al.
Headache|November 4, 2025
Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine studyJessica Ailani, Larry Charleston, Shannon Strom, et al.
The Journal of Headache and Pain|October 18, 2020
Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)Jessica Ailani, J Scott Andrews, Mallikarjuna Rettiganti, et al.
Pain and Therapy|April 24, 2023
The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative ReviewJessica Ailani, Stephanie J Nahas, Deborah I Friedman, et al.
Clinical Neurology and Neurosurgery|March 14, 2022
A retrospective evaluation of the combination of erenumab and onabotulinum toxin A for the prevention of chronic migraineArathi S Nandyala, Himanshu Suri, Carrie O Dougherty, et al.
Brain Sciences|December 31, 2016
An Unusual Case of Post-Traumatic Headache Complicated by Intracranial HypotensionSara Siavoshi, Carrie Dougherty, Jessica Ailani, et al.
Cephalalgia : an International Journal of Headache|January 31, 2023
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative reviewBianca Raffaelli, Roberto De Icco, Michele Corrado, et al.
Pageof 12